Navigation Links
Canine Painkiller unveiled by Novartis

Novartis received approval from the Food and Drug Administration to begin marketing Deramaxx, a canine painkiller, which will be used to relieve post-operative pain in dogs. This drug being produced by a Novartis facility at Puerto Rico //is the result of a development project undertaken by Novartis Animal Health that was run for several years at veterinary clinics, colleges and its manufacturing facilities.

The marketing campaign for the drug was launched in late September and veterinarian offices were the primary focus. Novartis expects to spend $25 million to market Deramaxx with a goal of reaching every veterinarian in the country in the first year. The company is banking on pet owner appeal to make this new drug a success.


'"/>




Page: 1

Related medicine news :

1. A New Drug To Address Canine Obesity
2. Hope for Obese Canines
3. Painkillers Do Not Shorten Dying Patients Lives
4. Painkiller Linked to Deaths
5. Painkillers may protect against Alzheimers disease
6. Painkillers may raise miscarriage risk
7. Painkillers Increase Risk of Miscarriage
8. In The Habit Of Taking Painkillers For Your Chronic Headache? Time To Switch Over
9. Aspirin Might Counter Side Effects of Cox-2 Painkillers
10. Botox Can Be a Competent Painkiller
11. Painkillers Lead To Liver Failure
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... Washington, DC (PRWEB) , ... April 28, 2017 ... ... Unplanned Pregnancy (The National Campaign) announces its support for the Access to ... by Sen. Jeanne Shaheen (D-NH) and Rep. Jackie Speier (D-CA), will help to ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce its ... has been in place since the RBMA was founded in 1968 with all board ... Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for Clinical ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... ... cardiac or hERG liability could substantially improve drug safety and minimize the cost ... provided for validating ion channel inhibition using cell lines and for cardiac toxicity ...
(Date:4/28/2017)... UTAH (PRWEB) , ... April 28, 2017 , ... ... Account Manager for the North East region. Côté has 20+ years of experience ... Prior to Phytomer, Côté worked with an array of high-end cosmetic brands, retail ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 19, 2017 The Mobile X-Ray product segment is ... CAGR during the forecast period Mobile X-Ray segment ... digital mobile X-Ray devices market, which is estimated to be ... at a CAGR of 7% over the forecast period. Mobile ... more than US$ 100 Mn in 2017 over 2016. The ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
Breaking Medicine Technology: